United Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade United Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About UTHR

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. 

CEO
Martine A. Rothblatt
CEOMartine A. Rothblatt
Employees
1,400
Employees1,400
Headquarters
Silver Spring, Maryland
HeadquartersSilver Spring, Maryland
Founded
1996
Founded1996
Employees
1,400
Employees1,400

UTHR Key Statistics

Market cap
25.42B
Market cap25.42B
Price-Earnings ratio
21.01
Price-Earnings ratio21.01
Dividend yield
—
Dividend yield—
Average volume
614.21K
Average volume614.21K
High today
—
High today—
Low today
—
Low today—
Open price
$592.24
Open price$592.24
Volume
0.00
Volume0.00
52 Week high
$609.35
52 Week high$609.35
52 Week low
$409.07
52 Week low$409.07

Stock Snapshot

With a market cap of 25.42B, United Therapeutics(UTHR) trades at $594.00. The stock has a price-to-earnings ratio of 21.01.

During the trading day, United Therapeutics(UTHR) stock saw an opening price of $592.24, a peak of —, and a bottom of —.

Trading activity shows a volume of 0, compared to an average daily volume of 614.21K.

The stock's 52-week range extends from a low of $409.07 to a high of $609.35.

The stock's 52-week range extends from a low of $409.07 to a high of $609.35.

UTHR News

Investing.com 14h
United Therapeutics CEO sells $5.5M in stock - Investing.com

...

United Therapeutics CEO sells $5.5M in stock - Investing.com
TipRanks 5d
United Therapeutics Announces $2 Billion Share Buyback

United Therapeutics ( (UTHR) ) just unveiled an announcement. On October 21, 2026, United Therapeutics Corporation’s board approved a new share repurchase prog...

TipRanks 5d
United Therapeutics announces new share repurchase program for up to $2B

United Therapeutics (UTHR) announced that the company’s Board of Directors has authorized a new share repurchase program for up to $2 billion of the company’s c...

Analyst ratings

82%

of 17 ratings
Buy
82.4%
Hold
11.8%
Sell
5.9%

People also own

Based on the portfolios of people who own UTHR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.